A WHO International Standard for neutralising antibodies to Chikungunya virus: development and evaluation
Sally A. Baylis, Constanze Yue, Marcus Panning, Marie-Christin Pauly et autres
0 citationsThe Lancet Microbe
Sergej Franz
Informations fournies par OpenAlex. Research Africa ne déduit ni nationalité, ni poste, ni coordonnées personnelles.
21Publications signalées
647Citations signalées
0Affiliations récentes
Domaines associés
SARS-CoV-2 and COVID-19 ResearchCOVID-19 Clinical Research StudiesMosquito-borne diseases and controlHIV Research and Treatmentinterferon and immune responses
Publications récentes
Exploring antiviral and anti-inflammatory effects of thiol drugs in COVID-19
Kritika Khanna, Wilfred W. Raymond, Jing Jin, Annabelle R. Charbit et autres
18 citationsAmerican Journal of Physiology-Lung Cellular and Molecular Physiology
Thiol Drugs Decrease SARS-CoV-2 Lung Injury In Vivoand Disrupt SARS-CoV-2 Spike Complex Binding to ACE-2In Vitro
Kritika Khanna, Wilfred W. Raymond, Jong‐Sik Jin, Annabelle R. Charbit et autres
0 citations
Human IFITM3 restricts chikungunya virus and Mayaro virus infection and is susceptible to virus-mediated counteraction
Sergej Franz, Fabian Pott, Thomas Zillinger, Christiane Schüler et autres
34 citationsLife Science Alliance
Selecting COVID ‐19 convalescent plasma for neutralizing antibody potency using a high‐capacity SARS‐CoV ‐2 antibody assay
Erin Meyer, Graham Simmons, Eduard Grebe, Michael Gannett et autres
26 citationsTransfusion
SARS-CoV-2 induces robust germinal center CD4 T follicular helper cell responses in rhesus macaques
Yashavanth Shaan Lakshmanappa, Sonny R. Elizaldi, Jamin W. Roh, Brian Schmidt et autres
88 citationsNature Communications
Thiol drugs decrease SARS-CoV-2 lung injury in vivo and disrupt SARS-CoV-2 spike complex binding to ACE2 in vitro
Kritika Khanna, Wilfred W. Raymond, Jing Jin, Annabelle R. Charbit et autres
24 citationsbioRxiv (Cold Spring Harbor Laboratory)
SARS-CoV-2 seroprevalence and neutralizing activity in donor and patient blood
Dianna Ng, Gregory M. Goldgof, Brian R. Shy, Andrew G. Levine et autres
184 citationsNature Communications
Human IFITM3 restricts Chikungunya virus and Mayaro virus infection and is susceptible to virus-mediated counteraction
Sergej Franz, Thomas Zillinger, Fabian Pott, Christiane Schüler et autres
2 citationsbioRxiv (Cold Spring Harbor Laboratory)
Selecting COVID-19 Convalescent Plasma for Neutralizing Antibody Potency Using a High-capacity SARS-CoV-2 Antibody Assay
Erin Meyer, Graham Simmons, Eduard Grebe, Michael Gannett et autres
8 citationsmedRxiv
SARS-CoV-2 infection induces robust germinal center CD4 T follicular helper cell responses in rhesus macaques
Sonny R. Elizaldi, Yashavanth Shaan Lakshmanappa, Jamin W. Roh, Brian Schmidt et autres
5 citationsResearch Square
SARS-CoV-2 seroprevalence and neutralizing activity in donor and patient blood from the San Francisco Bay Area
Dianna Ng, Gregory M. Goldgof, Brian R. Shy, Andrew G. Levine et autres
85 citationsmedRxiv
BNTIC News n’est pas le producteur de ces données. Recherche à la demande dans Crossref et Europe PMC, sans clé ; OpenAlex reste optionnel. Aucun service payant requis, aucune réponse conservée. Sources et limites.